文献速递慢性肾脏病肾血管病与高血压

晚期慢性肾脏病的内皮依赖与非内皮依赖血管功能

Endothelium-Dependent and -Independent Vascular Function in Advanced Chronic Kidney Disease.
PubMed 文献 · Clin J Am Soc Nephrol · 2017-08-07

该匹配队列分析从单中心1259名参与者中随机选取,比较晚期CKD患者与肾功能保留但分别无 overt 血管病、高血压、冠心病者的血流介导扩张(内皮依赖)和硝酸甘油介导扩张(内皮非依赖)。晚期CKD的内皮依赖功能有降低趋势但未达统计学显著,而内皮非依赖功能显著低于其他三组,提示CKD与其他疾病状态血管功能障碍的严重程度和病理生理不同。

要点

  • 晚期CKD患者内皮非依赖血管功能显著低于无 overt 血管病、高血压和冠心病患者。
  • 晚期CKD患者内皮依赖血管功能有降低趋势,但校正分析未达统计学显著。
  • 晚期CKD患者血流介导扩张处于最低三分位的校正OR为4.84(95%CI 2.09-11.25)。

核心结论

  • 晚期CKD患者存在内皮依赖血管功能受损,与临床明显血管病但肾功能保留者相似。
  • 内皮非依赖功能显著降低仅见于CKD组,提示CKD与其他疾病状态血管功能障碍的严重程度和病理生理存在差异。

研究设计与样本

  • 匹配队列分析,从单中心1259名参与者中随机选取。
  • 晚期CKD组70例,按1:1匹配至肾功能保留且无 overt 血管病、高血压和冠心病三组对照。
  • 测量肱动脉血流介导扩张(内皮依赖)和硝酸甘油介导扩张(内皮非依赖)。

主要发现

  • 血流介导扩张均值±SEM:晚期CKD 5.4%±0.5%,无 overt 血管病7.3%±0.6%,高血压6.2%±0.5%,冠心病5.8%±0.5%,校正分析P=0.05。
  • 硝酸甘油介导扩张校正值:晚期CKD 6.9%±0.8%,无 overt 血管病11.8%±0.9%,高血压11.0%±0.7%,冠心病10.5%±0.7%,P<0.001。
  • 以无 overt 血管病为参照,血流介导扩张处于最低三分位的校正OR:晚期CKD 4.84(95%CI 2.09-11.25),冠心病4.17(95%CI 1.76-9.87)。
  • 硝酸甘油介导扩张处于最低三分位的校正OR:晚期CKD 24.25(95%CI 7.16-82.13),高血压0.79(95%CI 0.23-2.77),冠心病2.34(95%CI 0.74-7.40)。

临床怎么用

  • 晚期CKD患者即使无临床血管病,也应关注血管功能障碍,尤其是内皮非依赖功能显著受损。
  • 内皮非依赖功能显著降低或有助于识别CKD相关血管病变的独特病理生理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: CKD is associated with increased cardiovascular risk not fully attributable to traditional risk factors. We compared endothelium-dependent and -independent vascular function among individuals with advanced CKD with function in those with vascular disease but preserved kidney function. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Matched cohort analysis randomly selected from 1259 participants at a single center with measurements of brachial artery flow-mediated dilation, an endothelium-dependent process, and nitroglycerin-mediated dilation, an endothelium-independent process. Patients with advanced CKD (n=70) were matched 1:1 to controls with preserved kidney function and (1) no overt vascular disease, (2) hypertension, and (3) coronary artery disease. RESULTS: The trend toward lower flow-mediated dilation (mean±SEM) in advanced CKD (5.4%±0.5%) compared with no overt vascular disease (7.3%±0.6%), hypertension (6.2%±0.5%), and coronary artery disease (5.8%±0.5%) did not reach statistical significance in adjusted analyses (P=0.05). Nitroglycerin-mediated dilation was lower in advanced CKD compared with in the other groups (adjusted nitroglycerin-mediated dilation: 6.9%±0.8%, 11.8%±0.9%, 11.0%±0.7%, and 10.5%±0.7% in advanced CKD, no overt vascular disease, hypertension, and coronary artery disease groups, respectively; P<0.001). Using tertiles generated from the full cohort and no overt vascular disease as the reference, the adjusted odds of flow-mediated dilation falling within the lowest tertile was higher in both the advanced CKD (odds ratio, 4.84; 95% confidence interval, 2.09 to 11.25) and coronary artery disease (odds ratio, 4.17; 95% confidence interval, 1.76 to 9.87) groups. In contrast, the adjusted odds of lowest tertile nitroglycerin-mediated dilation was higher in advanced CKD (odds ratio, 24.25; 95% confidence interval, 7.16 to 82.13) but not in the hypertension (odds ratio, 0.79; 95% confidence interval, 0.23 to 2.77) or coronary artery disease (odds ratio, 2.34; 95% confidence interval, 0.74 to 7.40) group. CONCLUSIONS: Impairment in endothelium-dependent vascular function is present in patients with CKD and those with clinically evident vascular disease but preserved kidney function. In contrast, substantial reduction in endothelium-independent function was observed only in the CKD group, suggesting differences in severity and pathophysiology of vascular dysfunction between CKD and other disease states.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Kopel T, Kaufman JS, Hamburg N, et al. Endothelium-Dependent and -Independent Vascular Function in Advanced Chronic Kidney Disease. Clin J Am Soc Nephrol. 2017. PMID: 28784655. doi:10.2215/CJN.12811216

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。